…that produce T-cells, which help maintain an individual’s ability to fight off infection. The condition results in the formation of immature, or ill-developed, T-cells that accumulate and overwhelm their normal…
…work. “To be honest, when she first called I told her she had the wrong department,” Di Silvio told me. But when they met, they spent hours talking about the…
…therapy is the most common treatment for adrenal disorders like Addison’s. However, with this study opening the door to approaches using regenerative medicine techniques, there is potential for the replacement…
…neuroendocrine tumors (GEP-NETs). GEP-NETs are a rare type of cancer that arises from the neuroendocrine cells found throughout the gastrointestinal tract and pancreas. These cells produce hormones and neurotransmitters that…
…healthy cells. (Left) Typical carcinoma cell staining from a bladder using Light Microscopy and Papanicolaou stain (Source: doi 10.1186/1742-6413-2-18). Right: Flourescence of carcinoma cells using the VitaDX’s test with the…
…culturing of patient-derived biopsy tissue to test standard and personalized therapies. Another possible application is to add immune cells to the circulation to study the infiltration of tumor tissue with…
…would make the cells become cancerous and transformed them into pancreatic cells. Before injecting them into the mouse, the cells were infected with viruses that enhanced the immune system response…
…both tumor cells and healthy cells. AFM13, on the other hand, is designed to treat CD30-positive malignancies including Hodgkin lymphoma (HL) and T-cell lymphoma (TCL – one of the deadliest…
…really a “pre-announcement,” as it’s a project we’re working on. The target for us is a listing in the first half of 2017, but it’s all dependent on market conditions….
…the proteins that they express – during the study, a technique that could help to unearth more information about other diseases. Typically, every cell in the body contains 23 pairs…
Today, we’re in Paris, visiting SparingVision, a biotech trying to combat blindness using a protein that slows down the degeneration of cone cells in the retina. Mission: SparingVision uses a…